Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Combination of Temsirolimus and Bevacizumab in Patient With Metastatic Renal Cell Carcinoma (TORAVA)

This study has been completed.
Information provided by (Responsible Party):
Centre Leon Berard Identifier:
First received: February 8, 2008
Last updated: February 14, 2013
Last verified: February 2013